Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes

Diab Vasc Dis Res. 2008 Sep;5(3):216-8. doi: 10.3132/dvdr.2008.036.

Authors

David R Matthews¹, Apostolos Tsapas

Affiliation

¹ Professor of Diabetes Medicine, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK. [email protected]

PMID: 18777497
DOI: 10.3132/dvdr.2008.036

No abstract available

Publication types

Historical Article
Research Support, Non-U.S. Gov't

MeSH terms

Blood Glucose / drug effects*
Cardiovascular Diseases / etiology
Cardiovascular Diseases / history
Cardiovascular Diseases / metabolism
Cardiovascular Diseases / prevention & control*
Clinical Trials as Topic* / history
Clinical Trials as Topic* / methods
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / history
Diabetes Mellitus, Type 2 / metabolism
Evidence-Based Medicine
Glycated Hemoglobin / metabolism*
History, 20th Century
History, 21st Century
Humans
Hypoglycemic Agents / history
Hypoglycemic Agents / therapeutic use*
Practice Guidelines as Topic
Research Design
Treatment Outcome

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
hemoglobin A1c protein, human